Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Friday, April 19, 2024

Biotechnology

Pharmaceutical Filtration Market Size Worth USD 43.96 Billion in 2030 | CAGR: 10.51%

New Delhi, August 18, 2023:  According to Adroit Market Research, the Global Pharmaceutical Filtration Market size was estimated at USD 19.99 billion and is expected to...

Avesthagen’s Teestar® Botanical Chewables Named Finalist For NutraIngredients-Asia 2023 Award Singapore

NEW DELHI,September  01 , 2023: Teestar® botanical chewables by Avesthagen Limited, a product designed for sugar and weight management, specifically targeting pre-diabetic and diabetic...

IT & Software Support

Wipro GE Healthcare keen to make diagnostics affordable to all

Wipro GE Healthcare is keen to invest in technologies that are affordable to all.

Terri Bresenhem, President and Chief Executive, GE Healthcare, told reporters here on Wednesday that the company has not only been expanding its presence in India for over two decades now, but investing at least 30 per cent more in recent years. “The investment is both in terms of manpower and strengthening our research and development facility,” she said.

INDIA MANUFACTURE

“We are striving to make healthcare affordable to all. While most medical equipment companies that have established their presence here import close to 80 per cent of their equipment, our import component is less. At GE Healthcare, we design and manufacture 30 per cent of the equipment in India. We have a strong research team, high quality thinkers and innovators here,” she added.

Appointments

Takeda appoints Serina Fischer as the General Manager for India

New Delhi, March 03, 2022: Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, announced the appointment of Serina Fischer as its General Manager...

Awards

Financial Results

Approvals

Clinical Trails

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Dr Agarwals Eye Hospital, Mumbai sponsors ‘LIMBS ON WHEELS’, a customized van for Inali...

Mumbai, September 23,2022: Padmashree Prof Dr. S.Natarajan, Chief clinical services, Aditya Jyot Eye Hospital, A unit of Dr Agarwals Eye Hospital, Wadala, Mumbai today...

Maxivision Super Speciality Eye Hospitals signed a Memorandum of Understanding with the Government of...

Chennai, September 13, 2023:  Maxivision Super Speciality Eye Hospitals ("Maxivision"), one of India's leading and fastest-growing chain of private eye care hospitals signed a  Memorandum of Understanding with the Government of Tamil Nadu today to set up eye hospitals across...

Dr. Agarwals Eye Hospitals opens high-end eyecare facility in Chembur, its 10th in Mumbai

Mumbai, October 05, 2023:  Dr. Agarwals Eye Hospitals has opened a state-of-the-art eyecare hospital in Chembur, Mumbai, at Signature Business Park. The facility, spread...

Product News

Media Partners

Spotlight

Investments

Packaging

Latest News

Informa Markets in India introduces AMWC India 2023: The Transformative Aesthetic and Anti-Aging Event...

Mumbai, September 12, 2023:  The Aesthetic and Anti-Aging Medicine World Congress (AMWC) is set to make a remarkable debut in India with AMWC India...

Rare Types of Pancreatic Cancer: Understanding and Treatment

Dr. Ajay Mehta, Director and Head Surgical Oncology, HCG Cancer Centre, Nagpur Pancreatic cancer is a formidable adversary, notorious for its aggressive nature and high...

South India’s First Hospital to Harness Advanced Laser Innovation: Gleneagles Hospital, Kengeri Launches RecoSMA...

Bengaluru, September  30, 2023:  In a monumental stride towards advancing healthcare in South India, Gleneagles Hospital, Kengeri proudly introduces RecoSMA laser technology. This cutting-edge...

Dental Care

Hospital Management

Drug Discovery & Development

Drug Discovery Unit (DDU), University of Dundee Licenses GVK BIO Online SAR Database (GOSTAR)

Hyderabad, Andhra Pradesh, India, Wednesday, April 10, 2013 -- (Business Wire India) -- GVK Biosciences (GVK BIO) today announced that it has licensed its Online SAR Database - GOSTAR to the Drug Discovery Unit (DDU) at the University of Dundee. GOSTAR, a manually curated database, has been developed over the span of a decade by a team comprising of more than 200 curators. The product issued globally in various areas such as pharmaceuticals, academics, government sectors, apart from numerous publications that cite the data contained in GOSTAR. GOSTAR contains over 6 million compounds manually curated through the screening of over 2 million patents and 400,000 journals and it also contains more than 18 million quantitative SAR points.

Suppliers

Technology

Companies

India-Sweden Healthcare Innovation Centre partners with the Directorate of Health Services...

National, February 15, 2023: Enhancing its efforts toward early detection of Lung diseases, India-Sweden healthcare Innovation Centre and its knowledge partner AstraZeneca India collaborated with the Directorate...

Marketing

Our Partners

Machinery & Equipments